v3.26.1
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 221,377 $ 38,278 $ 245,742 $ 76,157
General and administrative 24,663 8,468 45,638 15,036
Total operating expenses 246,040 46,746 291,380 91,193
Loss from operations (246,040) (46,746) (291,380) (91,193)
Interest income, net 4,956 3,474 10,952 5,713
Other income (expense) 13 (2) 18 (5)
Total other income, net 4,969 3,472 10,970 5,708
Net loss $ (241,071) $ (43,274) $ (280,410) $ (85,485)
Net loss per share attributable to common stockholders - basic (in USD per share) $ (2.85) $ (0.66) $ (3.35) $ (1.44)
Net loss per share attributable to common stockholders - diluted (in USD per share) $ (2.85) $ (0.66) $ (3.35) $ (1.44)
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares) 84,727,282 65,451,297 83,786,245 59,341,368
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares) 84,727,282 65,451,297 83,786,245 59,341,368